December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

74.57 +0.08 (+0.11%)
Streaming Delayed Price Updated: 11:16 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
News headline image
Hologic Stock Falls After Q3 Revenue Dip, But It Lifts Revenue and Profit Outlook ↗
Hologic Inc (NASDAQ: HOLX) posted Q3 adjusted EPS of $0.93, down from $0.95 a year ago and beating the consensus of $0.88 
Via Benzinga
News headline image
Analyst Expectations for Hologic's Future ↗
 
Via Benzinga
News headline image
Hologic Announces Financial Results for Third Quarter of Fiscal 2023
From Hologic, Inc.
Via Business Wire
News headline image
Hologic's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Expert Ratings for Hologic ↗
 
Via Benzinga
News headline image
What 9 Analyst Ratings Have To Say About Hologic ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 31, 2023 ↗
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
News headline image
Earnings Preview For Hologic ↗
 
Via Benzinga
News headline image
3 Top Analyst Picks Worth Your Attention Now ↗
These top analyst picks, offering robust upside ahead, represent a beacon amidst the stock market chaos at this time. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 ↗
 
Via Benzinga
News headline image
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2023 on Monday, July 31, 2023
From Hologic, Inc.
Via Business Wire
News headline image
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction ↗
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. 
Via Benzinga
News headline image
Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
From Hologic Inc.
Via Business Wire
News headline image
Time To Play Small Cap Life Science Stocks ↗
The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling. 
Via Talk Markets
News headline image
A New Groundbreaking Tool to Detect Colon Cancer Earlier
A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This... 
Via PressReach
News headline image
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family
From Hologic Inc.
Via Business Wire
News headline image
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review ↗
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
News headline image
Hologic to Webcast Presentation at the BofA Securities 2023 Healthcare Conference
From Hologic, Inc.
Via Business Wire
News headline image
Can Butterfly Network Spread its Wings in 2023?
Butterfly Network Inc. (NYSE: BFLY) is a medical imaging solutions company that makes point-of-demand portable ultrasound devices to bring medical imaging to h 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Hologic Announces Financial Results for Second Quarter of Fiscal 2023
From Hologic, Inc.
Via Business Wire
News headline image
Earnings Scheduled For May 1, 2023 ↗
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
News headline image
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2023 on Monday, May 1, 2023
From Hologic, Inc.
Via Business Wire
News headline image
Biotech And Life Science Trades: Q1 2023 Performance By The Numbers ↗
Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of... 
Via Talk Markets
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs... 
Via FinancialNewsMedia
News headline image
Hologic to Webcast Presentation at the Cowen 43rd Annual Health Care Conference
From Hologic, Inc.
Via Business Wire
News headline image
Hologic “Making a World of Difference” Through Global Sustainability Impact
From Hologic, Inc.
Via Business Wire
News headline image
SMID Cap Life Science Update: Are You An Investor Or Trader? ↗
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
News headline image
Court of Appeals Affirms District Court Decision Invalidating Minerva Surgical Patent
From Hologic Inc.
Via Business Wire
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.